Mechanisms that Regulate Helicobacter pylori-Induced beta-catenin Activation
Mechanisms that Regulate Helicobacter pylori-Induced beta-catenin Activation
批准号:
8413057
负责人:
RICHARD M. PEEK
金额:
$23.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-01 至 2013-12-31
关键词:
AdherenceBindingBiologicalCancer EtiologyCessation of lifeDevelopmentEpithelialEpithelial CellsEpitheliumEventGastric AdenocarcinomaGastric AdenomaGastric Intraepithelial NeoplasiaGenesGerbilsHarvestHelicobacter pyloriHistologicIn VitroInflammationInjuryIntegration Host FactorsMalignant NeoplasmsMediatingMicrobeModelingMolecularMucositisMusNuclearNuclear TranslocationPathogenicityPathogenicity IslandPathway interactionsPersonsPhenotypePhosphorylationProtein Export PathwayReporterRiskRisk FactorsRodentSignal PathwaySignal TransductionSpecimenStagingStomachSystemTranscriptional ActivationTransgenic Organismsbeta catenincancer riskcarcinogenesishigh riskin vivomalignant stomach neoplasmmutantprototypereceptorresponse
中文摘要
胃腺癌是世界上第二大癌症相关死亡原因。幽门螺杆菌是
这种恶性肿瘤的最大已知风险因素,然而只有一小部分感染者曾患上癌症。
一个增加癌症风险的幽门螺杆菌决定因素是CAG致病性岛和几个CAG基因
编码IV型细菌分泌系统的组成部分,该系统具有输出蛋白质的功能(例如,CagA)
不能寄生上皮细胞。一个可能影响癌症发生的宿主效应因子是下游的Li-catenin。
Wnt途径的组成部分。当Wnt信号不活跃时,(L-连环蛋白被结构性磷酸化
和降解;Wnt与其受体结合抑制G-catenin磷酸化,导致其核
影响癌症发生的基因的积累和转录激活。核子
FI-Catenin在胃腺瘤和不典型增生标本中积聚增加,组织学分期
先于胃腺癌。我们的初步研究表明,一种适应啮齿动物的幽门螺杆菌
Ag株(7.13)能在24周内快速诱导高胃泌素血症(INS-GAS)小鼠发生胃癌。
Vlong olian沙土鼠出生4周,该菌株7.13诱导G-连环蛋白的核转位并激活
一个B-连环蛋白反应的体外报告,表明Li-连环蛋白对这个原型有功能反应
紧张。幽门螺杆菌对IS-catenin的激活依赖于CagA转位到上皮细胞中,并且
从CAG感染者采集的胃上皮中U-连环蛋白的核积聚增加,
与携带CAG菌株的受试者或未感染的人相比。我们的假设是幽门螺杆菌CAG*
菌株选择性地激活宿主信号通路,例如由R-连环蛋白介导的信号通路,从而
调节细胞反应,有助于增加与这些相关的致癌风险
菌株。因此,我们的具体目标是:
1.明确幽门螺杆菌活性成分在体内外对S-连环蛋白激活的影响。
2.确定调控H.py/和/或H.py诱导FI-catenin活化的真核信号通路。
3.确定上皮细胞对致癌幽门螺杆菌和突变菌株的分子反应的差异
使用转基因小鼠的胃癌模型。
英文摘要
Gastric adenocarcinoma is the second leading cause of cancer-related death in the world. H. pylori is the
strongest known risk factor for this malignancy, yet only a fraction of infected persons ever develop cancer.
One H. pylori determinant that augments cancer risk is the cag pathogenicity island, and several cag genes
encode components of a type IV bacterial secretion system which functions to export proteins (e.g., CagA)
nto host epithelial cells. A host effector that may influence carcinogenesis is li-catenin, a downstream
component of the Wnt pathway. When Wnt signaling is inactive, (l-catenin is constitutively phosphorylated
and degraded; binding of Wnt to its receptor inhibits G-catenin phosphorylation, leading to its nuclear
accumulation and the transcriptional activation of genes that influence carcinogenesis. Nuclear
accumulation of fi-catenin is increased in gastric adenoma and dysplasia specimens, histologic stages that
precede gastric adenocarcinoma. Our preliminary studies now demonstrate that a rodent-adapted H. pylori
¿ag+ strain (7.13) rapidly induces gastric cancer in hypergastrinemic (INS-GAS) mice by 24 weeks and in
Vlongolian gerbils by 4 weeks and that strain 7.13 induces nuclear translocation of G-catenin and activates
a B-catenin-responsive reporter in vitro, indicating that li-catenin is functionally responsive to this prototype
strain. IS-catenin activation by H. pylori is dependent upon translocation of CagA into epithelial cells, and
nuclear accumulation of U-catenin is increased in gastric epithelium harvested from cag+-infected persons,
compared to subjects carrying cag strains or uninfected persons. Our hypothesis is that H. pylori cag*
strains selectively activate host signaling pathways, such as those mediated by R-catenin, thereby
regulating cellular responses that contribute to the augmentation in carcinogenic risk associated with these
strains. Thus, our specific aims are:
1. To define the effects of H. pylori constituents on activation of S-catenin in vitro and in vivo.
2. To determine the eukaryotic signaling pathways that regulate H. py/or/-induced fi-catenin activation.
3. To define differences in epithelial molecular responses to carcinogenic H. pylori versus mutant strains
using a transgenic murine model of gastric cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
H. Pylori Relationship to Digestive Diseases and Cancer
-
批准号:10846242
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2023
-
负责人:RICHARD M. PEEK
-
依托单位:
Administrative Core
-
批准号:8413062
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2013
-
负责人:RICHARD M. PEEK
-
依托单位:
Role of Iron and B-Catenin Activation in Gastric Carcinogenesis
-
批准号:9274160
-
项目类别:
-
资助金额:$28.23万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. Pylori-Induced Inflammation and Gastric Cancer
-
批准号:8011208
-
项目类别:
-
资助金额:$138.07万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. Pylori-Induced Inflammation and Gastric Cancer
-
批准号:7753610
-
项目类别:
-
资助金额:$145.09万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
Administrative Core
-
批准号:9274166
-
项目类别:
-
资助金额:$18.52万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. pylori-Induced Inflammation and gastric cancer
-
批准号:9203563
-
项目类别:
-
资助金额:$138.4万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. Pylori-Induced Inflammation and Gastric Cancer
-
批准号:8212343
-
项目类别:
-
资助金额:$135.36万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. pylori-Induced Inflammation and gastric cancer
-
批准号:8821584
-
项目类别:
-
资助金额:$137.54万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
Administrative Core
-
批准号:8632359
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
Role of Iron and B-Catenin Activation in Gastric Carcinogenesis
-
批准号:9248619
-
项目类别:
-
资助金额:$20.26万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. Pylori-Induced Inflammation and Gastric Cancer
-
批准号:8413056
-
项目类别:
-
资助金额:$125.26万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. pylori-induced inflammation and gastric cancer
-
批准号:7561133
-
项目类别:
-
资助金额:$151.48万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. pylori-Induced Inflammation and gastric cancer
-
批准号:8990355
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
Administrative Core
-
批准号:9248624
-
项目类别:
-
资助金额:$13.3万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
H. pylori-Induced Inflammation and gastric cancer
-
批准号:8607664
-
项目类别:
-
资助金额:$137.11万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
Administrative Core
-
批准号:8990361
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2009
-
负责人:RICHARD M. PEEK
-
依托单位:
Core C: Administrative Core
-
批准号:10352430
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2008
-
负责人:RICHARD M. PEEK
-
依托单位:
H. pylori-induced Inflammation and Gastric Cancer
-
批准号:10352426
-
项目类别:
-
资助金额:$132.08万
-
财政年份:2008
-
负责人:RICHARD M. PEEK
-
依托单位:
Mechanisms that Regulate Helicobacter pylori-Induced beta-catenin Activation
-
批准号:7617405
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2008
-
负责人:RICHARD M. PEEK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: